The effects of Gingko biloba, vitamin E and melatonin on bacterial translocation in thioacetamide-induced fulminant hepatic failure in rats

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 3, 2006, Pages 268-275

  Harputluoglu, Murat Muhsin Muhip ^a   Demirel, U ^a   Karadag, N ^a   Temel, I ^a   Bayraktar, M ^a   Firat, S ^a   Karahan, D ^a   Aladag, M ^a   Alan, H ^a   Ates, F ^a   Karincaoglu, M ^a   Hilmioglu, F ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antioxidants; Bacterial translocation; Fulminant hepatic failure; Oxidative stress; Platelet activating factor; Thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; GINKGO BILOBA EXTRACT; MELATONIN; THIOACETAMIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DRUG ACTIVITY; EDEMA; ESCHERICHIA COLI; LIPID PEROXIDATION; LIVER FAILURE; MALE; NONHUMAN; RAT; TREATMENT OUTCOME; VASODILATATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BACTERIAL TRANSLOCATION; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; GINKGO BILOBA; INTESTINES; LIPID PEROXIDATION; LIVER FAILURE, ACUTE; LYMPH NODES; MALE; MELATONIN; MESENTERY; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; SPLEEN; SURVIVAL RATE; THIOACETAMIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 33751316725     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. DE-SOUZA D.A., GREENE L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit. Care Med., 2005, 33: 1125-1135.
2. BISMUTH H., SAMUEL D., GUGENHEIM J. Emergency liver transplantation for fulminant hepatitis. Ann. Intern. Med., 1987, 107: 337-341.
3. RAKELA J., LANGE S.M., LUDWIG J. Fulminant hepatitis: Mayo Clinics experience with 34 cases. Mayo Clin. Proc., 1985, 60: 289-292.
4. ADAWI D., KASRAVI F.B., MOUN G., JEPPSSON B. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology, 1997, 25: 642-647.
5. LE VOYER T., CIOFFI W.G. Jr, PRATT L., SHIPPEE R., MC MANUS W.F., MASON A.D. Jr, PRUITT B.A. Jr. Alterations in intestinal permeability after thermal injury. Arch. Surg., 1992, 127: 26-29.
6. RIDDINGTON D.W., VENKATESH B., BOIVIlN C.M., BONSER R.S., ELLIOTT T.S., MARSHALL T., MOUNTFORD P.J., BION J.F. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA, 1996, 275: 1007-1012.
7. SWANK G.M., DEITCH E.A. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J. Surg., 1996, 20: 411-417.
8. CHIVA M., SORIANO G., ROCHAT I., PERALTA C., ROCHAT F., LLOVET T., MIRELIS B., SCHIFFRIN E.J., GUARNER C., BALANZO J. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J. Hepatol., 2002, 37:456-462.
9. KASRAVI F.B., WANG L., WANG X.D., MOLIN G., BENGMARK S., JEPPSSON B. Bacterial translocation in acute liver injury induced by D-galactosamine. Hepatology, 1996, 23: 97-103.
10. ZHANG F. Protective effect of a platelet activating factor antagonist in experimental liver injury. Zhonghua Yi Xue Za Zhi, 1990, 70: 375-378 (with English abstract).
11. LONGO W.E., POLITIES G., VERNAVA AM 3rd, DESHPANDE Y., NIEHOFF M., CHANDEL B., KULKARNI A., KAMINSKI D.L. Platelet-activating factor mediates trinitrobenzene induced colitis. Prostaglandins Leukot. Essent. Fatty Acids, 1994, 51: 419-424.
12. DE SOUZA L.J., SAMPIETRE S.N., ASSIS R.S., KNOWLES C.H., LEITE K.R., JANCAR S., MONTEIRO CUNHA J.E., MACHADO M.C. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. J. Gastrointest. Surg., 2001, 5: 364-370.
13. SUN Z., WANG X., DENG X., LASSON A., SOLTESZ V., BORJESSON A., ANDERSSON R. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. Dig. Surg., 2000, 17: 57-65.
14. GERTZ H.J., KIEFER M. Review about Gingko biloba special extract EGb 761 (Gingko). Curr. Pharm. Des., 2004, 10: 261-264.
15. ZHANG C., ZU J., SHI H., LIU J., QIN C. The effect of Ginkgo biloba extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CC14 rats. Am. J. Chin. Med., 2004, 32: 21-31.
16. PEHLIVAN M., DALBELER Y., HAZINEDAROGLU S., ARIKAN Y., ERKEK A.B., GUNAL O., TURKCAPAR N., TURKCAPAR A.G. An assessment of the effect of Ginkgo Biloba EGb 761 on ischemia reperfusion injury of intestine. Hepatogastroenterology, 2002, 49: 201-204.
17. TUCKER J.M., TOWNSEND D.M. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother, 2005, 59: 380-387.
18. NISHIDA S. Metabolic effects of melatonin on oxidative stress and diabetes mellitus. Endocrine, 2005, 27: 131-136.
19. MARNETT L.J. Oxy radicals, lipid peroxidation and DNA damage. Toxicology, 2002, 27: 219-222.
20. PAWA S., ALI S. Liver necrosis and fulminant hepatic failure in rats: protection by oxyanionic form of tungsten. Biochim. Biophys. Acta, 2004, 1688: 210-222.
21. BRUCK R., AEED H., AVNI Y., SHIRIN H., MATAS Z., SHAHMUROV M., AVINOACH I., ZOZULYA G., WEIZMAN N., HOCHMAN A. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J. Hepatol., 2004, 40: 86-93.
22. BRIDI R., CROSSETI F.P., STEFFEN V.M., HENRIQUES A.T. The antioxidant activity of standardized extract of Gingko biloba (EGb 761) in rats. Phytother. Res., 2001, 15: 449-451.
23. ILHAN A., GUREL A., ARMUTCU F., KAMISLI S., IRAZ M., AKYOL O., OZEN S. Ginkgo biloba prevents mobile phone-induced oxidative stresss in rat brain. Clin. Chim. Acta, 2004, 340: 153-162.
24. SARKAR K., GHOSH A., SIL P.C. Preventive and curative role of a 43kD protein from the leaves of the herb Cajanus indicus L on thioacetamide-induced hepatotoxicity in vivo. Hepatol. Res., 2005, 5: "in press".
25. CETINKAYA Z., ULGER H., AKKUS M.A., DOGRU O., CIFTER C., DOYMAZ M.Z., OZERCAN I.H. Influence of some substances on bacterial translocation in the rat. World J. Surg., 2002, 26: 9-12.
26. SEARLE P.L. The Berthelot or indophenol reaction and its use in the analytical chemistry of nitrogen - a review. Analyst., 1984, 109: 549-568.
27. BUEGE J.A., AUST S.D. Microsomal lipid peroxidation. Methods Enzymol., 1978, 52: 302-310.
28. GUARNER C., RUNYON B.A., YOUNG S., HECK M., SHEIKH M.Y. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J. Hepatol., 1997, 26: 1372-1378.
29. FINK M.P. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr. Opin. Crit. Care, 2003, 9: 143-151.
30. KINGSNORTH A.N., GALLOWAY S.W., FORMELA L.J. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br. J. Surg., 1995, 82: 1414-1420.
31. GRYPIOTI A.D., THEOCHARIS S.E., PAPADIMAS G.K., DEMOPOULOS C.A., PAPADOPOULOU-DAIFOTI Z., BASAYIANNIS A.C., MYKONIATIS M.G. Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. Arch. Toxicol., 2005, 79: 466-474.
32. GRYPIOTI A.D., THEOCHARIS S.E., DEMOPOULOS C.A., PAPADOPOULOU-DAIFOTI Z., BASAYIANNIS A.C., MYKONIATIS M.G. Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats. Liver Int., 2006, 26: 97-105.
33. YANG X.F., WANG N.P., LU W.H., ZENG F.D. Effects of Ginkgo biloba extract and tanshinone on cytochrome P-450 isozymes and glutathione transferase in rats. Acta Phamacol. Sin., 2003, 24: 1033-1038.
34. CHEN S.H., LIANG Y.C., CHAD J.C., TSAI L.H., CHANG C.C., WANG C.C., PAN S. Protective effects of Ginkgo biloba extract on the ethanol-induced gastric ulcer in rats. World J. Gastroenterol., 2005, 11: 3746-3750.
35. CANKURTARAN M., KAV T., YAVUZ B., SHORBAGI A., HALIL M., COSKUN T., ARSLAN S. Serum vitamin-E levels and its relation to clinical features in nonalcoholic fatty liver disease with elevated ALT levels. Acta Gastroenterol. Belg., 2006, 69: 5-11.
36. TUNEZ I., MUNOZ M.C., MEDINA F.J., SALCEDO M., FEIJOO M., MONTILLA P. Comparison of melatonin., vitamin E and L-carnitine in the treatment of neuro- and hepatotoxicity induced by thioacetamide. Cell Biochem. Funct., 2005, 24: "in press"
37. REIS E., KAMA N.A., COSKUN T., KORKUSUZ P., ORS U., AKSOY M., KULACOGLU S. Effects of octreotide and a-tocopherol on bacterial translocation in experimental intestinal obstruction: a microbiological, light and electronmicroscopical study. Hepatogastroenterology, 1997, 44: 656-663.
38. SCHIMPL G., PESENDORFER P., STEINWENDER G., FEIERL G., RATSCHEK M., HOLLWARTH M.E. The effect of vitamin C and vitamin E supplementation on bacterial translocation in chronic portal hypertensive and common-bile-duct- ligated rats. Eur. Surg. Res., 1997, 29: 187-194.
39. TAN D.X., REITER R.J., MANCHESTER L.C., YAN M.T., EL-SAWI M., SAINZ R.M., MAYO J.C., KOHEN R., ALLEGRA M., HARDELAND R. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top Med. Chem., 2002, 2: 181-197.
40. TUNEZ I., MUNOZ M.C., VILLAVICENCIO M.A., MEDINA F.J., DE PRADO E.P., ESPEJO I., BARCOS M., SALCEDO M., FEIJOO M., MONTILLA P. Hepato- and neurotoxicity induced by thioacetamide: protective effects of melatonin and dimethylsulfoxide. Pharmacol Res., 2005, 52: 223-228.
41. CRUZ A., PADILLO F.J., TORRES E., NAVARRETE C.M., MUNOZ-CASTANEDA J.R., CABALLERO F.J., BRICENO J., MARCHAL T., TUNEZ I., MONTILLA P., PERA C., MUNTANE J. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J. Pineal Res., 2005, 39: 143-150.
42. KARABAY G., ALDEMIR D., AKIN E., OGUS E., GUR G., BOYACIOGLU S., TURKOGLU S. The effect of melatonin treatment on oxidative and nitrosative stress in rats with thioacetamide-induced hepatic damage. Hepatol. Res., 2005, 31: 160-17.
43. JAHOVIC N., SENER G., CEVIK H., ERSOY Y., ARBAK S., YEGEN B.C. Amelioration of methotrexate-induced enteritis by melatonin in rats. Cell Biochem. Funct., 2004, 22: 169-178.
44. CUZZOCREA S., MAZZON E., SERRAINO I., LEPORE V., TERRANOVA M.L., CICCOLO A., CAPUTI A.P. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J. Pineal Res., 2001, 30: 1-12.
45. SILERI P., SICA G.S., GENTILESCHI P., VENZA M., BENAVOLI D., JARZEMBOWSKI T., MANZELLI A., GASPARI A.L. Melatonin reduces bacterial translocation after intestinal ischemia-reperfusion injury. Transplant. Proc., 2004, 36: 2944-2946.
46. KAZEZ A., DEMIRBAG M., USTUNDAG B., OZERCAN I.H., SAGLAM M. The role of melatonin in prevention of intestinal ischemia-reperfusion injury in rats. J. Pediatr. Surg., 2000, 35: 1444-1448.
47. CUZZOCREA S., ZINGARELLI B., COSTANTINO G., CAPUTI A.P. Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J. Pineal. Res., 1998, 25: 24-33.
48. YI J.H., NI R.Y., LUO D.D., LI S.L. Intestinal flora translocation and overgrowth in upper gastrointestinal tract induced by hepatic failure. World J. Gastroenterol., 1999, 5: 327-329.